8-K: Planet 13 Reports Q4 & Full Year 2025 Losses Amid Strategic Shifts

Planet 13 Holdings Inc. announced a Q4 2025 net loss of $4.6 million and a full-year net loss of $63.9 million, alongside strategic exits and new market entries.

Summary

• Q4 2025 revenue decreased by 16.7% to $25.2 million compared to $30.3 million in Q4 2024.
• Full-year 2025 revenue decreased by 11.2% to $103.4 million compared to $116.4 million in 2024.
• Q4 2025 net loss significantly improved to $4.6 million from $26.4 million in Q4 2024, which included an $18.9 million impairment.
• Full-year 2025 net loss worsened to $63.9 million from $47.8 million in 2024, including $29.8 million in non-cash impairment charges.
• Q4 2025 Adjusted EBITDA was a loss of $0.3 million, compared to break-even in Q4 2024.
• Full-year 2025 Adjusted EBITDA was a loss of $10.1 million, a significant decline from a $4.8 million gain in 2024.
• Cash decreased to $15.6 million at year-end 2025 from $23.4 million at year-end 2024.
• Total assets decreased to $152.3 million, while total liabilities increased to $101.2 million.
• The company completed a substantial exit from California and opened two new dispensaries in Florida.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a challenging financial report with significant revenue and profitability declines for the full year, despite some Q4 stabilization and strategic repositioning efforts. The company faces an uphill battle to achieve its cash flow positive goal for 2026.

Positives

• Q4 2025 net loss significantly improved to $4.6 million from $26.4 million in Q4 2024, although Q4 2024 included a large impairment charge.
• Operating expenses decreased in Q4 2025 to $13.1 million from $14.5 million in Q4 2024, and for the full year to $59.9 million from $61.3 million in 2024.
• Gross profit margin improved slightly in Q4 2025 to 44.6% from 43.2% in Q4 2024.
• Wholesale momentum returned in Nevada during Q4 2025.
• The company completed a substantially complete exit from California, which management stated removes a 'persistent drag'.
• A BHO lab in Florida positions the company to compete more effectively in that market.
• Net cash from investing activities was positive $2.53 million in 2025, compared to a negative $3.79 million in 2024, driven by asset sales.

Negatives

• Q4 2025 revenue decreased by 16.7% to $25.2 million, driven by the tourist environment in Las Vegas and competition in Florida.
• Full-year 2025 revenue decreased by 11.2% to $103.4 million, attributed to the same factors.
• Full-year 2025 gross profit declined by 28.9% to $39.9 million, with gross margin falling to 38.6% from 48.2% due to weaker flower quality in Florida and increased competition and price compression.
• Full-year 2025 net loss worsened by 33.7% to $63.9 million, including $29.8 million in non-cash impairment charges.
• Adjusted EBITDA shifted from break-even in Q4 2024 to a loss of $0.3 million in Q4 2025, and from a $4.8 million gain in 2024 to a $10.1 million loss for the full year 2025.
• Cash decreased to $15.6 million at December 31, 2025, from $23.4 million at December 31, 2024.
• Total assets decreased by $54.4 million to $152.3 million, while total liabilities increased by $7.2 million to $101.2 million.
• Net cash used in operating activities was $(14.19) million in 2025, a significant deterioration from $5.21 million provided in 2024.

Risks

• The company operates in states where licensed cannabis activity is legal, but it remains illegal under U.S. federal law.
• Forward-looking statements are subject to assumptions, risks, and uncertainties discussed under 'Risk Factors' in the Company's Annual Report on Form 10-K/A for the year ended December 31, 2025, and subsequent periodic reports.
• Competition in Florida and the tourist environment in Las Vegas negatively impacted revenue.
• Weaker flower quality in Florida and increased competition and price compression led to declining gross margins.

Future Outlook

Management's focus in 2026 is to reach cash flow positive and demonstrate the earnings power of the portfolio. The company anticipates building on the foundation laid in Q4 2025, with revenue stabilization, returning wholesale momentum in Nevada, and a cleaner, more focused portfolio after the California exit. The federal posture on rescheduling cannabis is seen as a potentially consequential shift for the industry.

Management Comments

• "Q4 began the turnaround we were looking for. Revenue stabilized across our footprint during a seasonally soft period, wholesale momentum returned in Nevada, and we exited the quarter with a cleaner, more focused portfolio. We still have a long way to go, but the foundation is in place and we are ready to build on it." Larry Scheffler, Co-CEO.
• "For the first time in several years, the operational and regulatory environment is moving in the same direction as our strategy. The California exit removes a persistent drag, the BHO lab positions us to compete more effectively in Florida, and the federal posture on rescheduling represents the most consequential potential shift this industry has seen. Our focus in 2026 is to reach cash flow positive and demonstrate the earnings power of this portfolio." Bob Groesbeck, Co-CEO.

Industry Context

StockSavvy.ai notes that Planet 13's strategic exit from California and focus on Florida, including a new BHO lab, aligns with a broader industry trend of companies optimizing their operational footprint for profitability in key growth markets. The mention of the federal posture on rescheduling cannabis highlights the significant regulatory tailwinds that could reshape the U.S. cannabis industry, potentially benefiting well-positioned multi-state operators like Planet 13.

Stakeholder Impact

• Shareholders: Negative impact due to significant net losses, declining revenue, and worsening Adjusted EBITDA, leading to a decrease in total assets and cash. The stock price is likely to be negatively affected.
• Employees: No direct impact mentioned, but strategic shifts and focus on efficiency could imply future operational adjustments.
• Customers: New dispensaries in Florida and a new rewards program could benefit customers in those markets.
• Creditors: Increased total liabilities and decreased cash could raise concerns, though specific details on debt covenants or repayment issues are not provided.

Next Steps

• Reach cash flow positive in 2026.
• Demonstrate the earnings power of the portfolio in 2026.
• Build on the foundation established in Q4 2025.
• Host a conference call on March 25, 2026, at 5:00 p.m. ET to discuss results, business highlights, strategy, and outlook.

Key Dates

Recommendation

The company reported significant declines in revenue and profitability for both Q4 and the full year 2025, with a substantial increase in net loss and a shift to negative Adjusted EBITDA. While management highlights strategic repositioning and a focus on becoming cash flow positive in 2026, the current financial trajectory, including decreasing cash and increasing liabilities, indicates ongoing operational challenges and a deteriorating financial position. The market is likely to react negatively to these results, suggesting a 'sell' recommendation for investors.

Keywords

Cannabis, Marijuana, Dispensary, Vertically Integrated, Nevada, Florida, Illinois, Financial Results, Q4 2025, Full Year 2025, Revenue, Net Loss, Adjusted EBITDA, SEC Filing, PLTH, PLNH, Cannabis Industry, Retail Cannabis